Skip to main content
SpringerLink
Log in

Headache

  • Chapter
  • First Online:
Fibromyalgia

  • 1978 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Marcus DA, Bernstein C, Rudy TE. Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyaglia syndrome. Clin Rheumatol. 2005;24:595–601.

    Article  PubMed  Google Scholar 

  2. Ifergane G, Buskila D, Simiseshvely N, Zeev K, Cohen H. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia. 2006;26:451–6.

    Article  PubMed  CAS  Google Scholar 

  3. Peres MF, Young WB, Kaup AO, Zukerman E, Silberstein SD. Fibromyalgia is common in patients with transformed migraine. Neurology. 2001;57:1326–8.

    Article  PubMed  CAS  Google Scholar 

  4. Tajti J, Uddman R, Edvinsson L. Neuropeptide localization in the “migraine generator” region of the human brainstem. Cephalalgia. 2001;21:96–101.

    Article  PubMed  CAS  Google Scholar 

  5. Obermann M, Gizewski ER, Limmroth V, Diener HC, Katsarava Z. Symptomatic migraine and pontine vascular malformation: evidence for a key role of the brainstem in the pathophysiology of chronic migraine. Cephalalgia. 2006;26:763–6.

    Article  PubMed  CAS  Google Scholar 

  6. Ifergane G, Shelef I, Buskila D. Migraine and fibromyalgia developing after a pontine hemorrhage. Cephalalgia. 2007;27:191.

    Article  PubMed  Google Scholar 

  7. Panconesi A, Bartolozzi ML, Guidi L. Migraine pain: reflections against vasodilation. J Headache Pain. 2009;10:317–25.

    Google Scholar 

  8. Okifuji A, Turk DC, Marcus DA. Comparison of generalized and localized hyperalgesia in patients with recurrent headache and fibromyalgia. Psychosom Med. 1999;61:771–80.

    PubMed  CAS  Google Scholar 

  9. Felício AC, Bischuette DB, dos Santos WC, et al. Epidemiology of primary and secondary headaches in a Brazilian tertiary-care center. Arq Neuropsiquiatr. 2006;64:41–4.

    Article  PubMed  Google Scholar 

  10. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006;26:1097–105.

    Article  PubMed  CAS  Google Scholar 

  11. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edn. Cephalalgia. 2004;24:1–160.

    Google Scholar 

  12. Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology. 2003;61:375–82.

    Article  PubMed  CAS  Google Scholar 

  13. Ertas M, Baykan B, Tuncel D, et al. A comparative ID migraine™ screener study in ophthalmology, ENT and neurology out-patient clinics. Cephalalgia. 2009;29:68–75.

    Article  PubMed  CAS  Google Scholar 

  14. Evans RW, Mannix LK. Triptans for migraine prodrome. Headache. 2002;42:83–4.

    Article  PubMed  Google Scholar 

  15. Aurora SK, Barrodale PM, McDonald SA, Jakubowski M, Burstein R. Revisiting the efficacy of sumatriptan therapy during the aura phase of migraine. Headache. 2009;49:1001–4.

    Google Scholar 

  16. Holroyd KA, France JL, Cordingley GE, et al. Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. J Consult Clin Psychol. 1995;63:327–30.

    Article  PubMed  CAS  Google Scholar 

  17. Peroutka SJ, Lyon JA, Swarbrick J, Lipton RB, Kolodner K, Goldstein J. Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: a randomized, double-blind, crossover study. Headache. 2004;44:136–41.

    Article  PubMed  Google Scholar 

  18. Mathew NT, Kailasam J, Gentry P, Chernyshev O. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial. Headache. 2000;40:464–5.

    Article  PubMed  CAS  Google Scholar 

  19. Diener HC, Dodick DW, Goadsby PJ, et al. Identification of negative predictors of pain-free response to triptans: analysis of the eletriptan database. Cephalalgia. 2007;28:35–40.

    PubMed  Google Scholar 

  20. Krymchantowski AV, Barbosa JS. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study. Cephalalgia. 2002;22:309–12.

    Article  PubMed  CAS  Google Scholar 

  21. Salvatore CA, Hershey JC, Corcoran HA, et al. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine. J Pharmacol Exp Ther. 2008;324:416–21.

    Article  PubMed  CAS  Google Scholar 

  22. Ho TW, Ferrari MD, Dodick DW, et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet. 2008;372:2115–23.

    Article  PubMed  CAS  Google Scholar 

  23. Ho TW, Mannix LK, Fan X, et al. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology. 2008;70:1304–12.

    Article  PubMed  CAS  Google Scholar 

  24. Vause C, Bowen E, Spierings E, Durham P. Effect of carbon dioxide on calcitonin gene-related peptide secretion from trigeminal neurons. Headache. 2007;47:1385–97.

    PubMed  Google Scholar 

  25. Spierings G. Abortive treatment of migraine headache with non-inhaled, intranasal carbon dioxide: a randomized, double-blind, placebo-controlled, parallel-group study. Headache. 2005;45:809.

    Google Scholar 

  26. Burstein R, Levy D, Jakubowski M. Effects of sensitization of trigeminovascular neurons to triptan therapy during migraine. Rev Neurol. (Paris) 2005;161:658–60.

    Article  CAS  Google Scholar 

  27. Jones J, Pack S, Chun E. Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Ann Emerg Med. 1996;14:262–4.

    CAS  Google Scholar 

  28. Friedman BW, Esses D, Soloranzo C, et al. A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine. Ann Emerg Med. 2008;52:399–406.

    Article  PubMed  Google Scholar 

  29. Gruppo LQ. Intravenous Zofran for headache. J Emerg Med. 2006;31:228–9.

    Article  PubMed  Google Scholar 

  30. Goadsby PJ, Ferrari MD, Olesen J, Mills JG. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis. Cephalalgia. 2009;29:742–50.

    Article  PubMed  CAS  Google Scholar 

  31. Calabresi P, Galletti F, Rossi C, Sarchielli P, Cupini LM. Antiepileptic drugs in migraine: from clinical aspects to cellular mechanism. Trends Pharmacol Sci. 2008;28:188–95.

    Article  Google Scholar 

  32. Masdrakis VG, Oulis P, Karakatsanis NA, et al. Remission of migraine attacks in a patient with depression who is taking pregabalin. Clin Neuropharmacol. 2008;31:238–40.

    Article  PubMed  Google Scholar 

  33. Taylor AP, Adelman JU, Freeman MC. Efficacy of duloxetine as a migraine prevention medication: possible predictors of response in a retrospective chart review. Headache. 2007;47:1200–3.

    Article  PubMed  Google Scholar 

  34. Volpe FM. An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache. J Clin Psychiatry. 2008:e1–6.

    Google Scholar 

  35. http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm. Accessed February 2008.

  36. Fernández-de-las-Peñas C, Madeleine P, Caminero AB, et al. Generalized neck-shoulder hyperalgesia in chronic tension-type headache and unilateral migraine assessed by pressure pain sensitivity topographical maps of the trapezius muscle. Cephalalgia, in press.

    Google Scholar 

  37. Fernández-de-las-Peñas C, Caminero AB, Madeleine P, et al. Multiple active myofascial trigger points and pressure pain sensitivity maps in the temporalis muscle are related in women with chronic tension type headache. Clin J Pain. 2009;25:506–12.

    Article  PubMed  Google Scholar 

  38. Ga H, Choi J, Park C, Yoon H. Acupuncture needling versus lidocaine injection of trigger points in myofascial pain syndrome in elderly patients – a randomized trial. Acupunct Med. 2007;25:130–6.

    Article  PubMed  Google Scholar 

  39. Ashkenazi A, Levin M. Greater occipital nerve block for migraine and other headaches: is it useful? Curr Pain Headache Rep. 2007;11:231–5.

    Article  PubMed  Google Scholar 

  40. Ashkenazi AA, Matro R, Shaw JW, Abbas MA, Silberstein SD. Greater occipital nerve block using local anesthetics alone or with triamcinolone for transformed migraine: a randomized comparative study. J Neurol Neurosurg Psychiatry. 2008;79:415–7.

    Article  PubMed  CAS  Google Scholar 

  41. Loukas M, El-Sedfy A, Tubbs RS, et al. Identification of greater occipital nerve landmarks for the treatment of occipital neuralgia. Folia Morph. 2006;65:337–42.

    CAS  Google Scholar 

  42. Afridi SK, Shields KG, Bhola R, Goadsby PJ. Greater occipital nerve injection in primary headache symptoms – prolonged effects from a single injection. Pain. 2006;122:126–9.

    Article  PubMed  CAS  Google Scholar 

  43. Schürks M, Diener H, Goadsby P. Update on the prophylaxis of migraine. Curr Treat Opt Neurol. 2008;10:20–9.

    Article  Google Scholar 

  44. Li Y, Liang F, Yang X, et al. Acupuncture for treating acute attacks of migraine: a randomized controlled trial. Headache. 2009;49:805–16.

    Article  PubMed  Google Scholar 

  45. Marcus DA. Headache simplified. Nr Shrewsbury, UK: TFM Publishing; 2008.

    Google Scholar 

  46. Marcus DA. Chronic pain. A primary care guide to practical management, 2nd edn. Totowa, NJ: Humana Press; 2009.

    Google Scholar 

  47. Marcus DA, Bain, PA. Effective migraine treatment in pregnant and lactating women. New York, NY: Springer; 2009.

    Google Scholar 

  48. Lau B, Lovell MR, Collins MW, Pardini J. Neurocognitive and symptom predictors of recovery in high school athletes. Clin J Sport Med. 2009;19:216–21.

    Article  PubMed  Google Scholar 

  49. Medina JL, Diamond S. The role of diet in migraine. Headache. 1978;18:31–4.

    Article  PubMed  CAS  Google Scholar 

  50. Mosek A, Korczyn AD. Yom Kippur headache. Neurology. 1995;45:1953–5.

    Article  PubMed  CAS  Google Scholar 

  51. Topacoglu H, Karcioglu O, Yuruktumen A, et al. Impact of Ramadan on demographics and frequencies of disease-related visits in the emergency department. Int J Clin Pract. 2005;59:900–5.

    Article  PubMed  CAS  Google Scholar 

  52. Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005;45:904–10.

    Article  PubMed  Google Scholar 

  53. Hozawa A, Houston T, Steffes MW, et al. The association of cigarette smoking with self-reported disease before middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Pre Med. 2006;42:193–9.

    Article  Google Scholar 

  54. Payne TJ, Stetson B, Stevens VM, Johnson CA, Penzien DB, Van Dorsten B. Impact of cigarette smoking on headache activity in headache patients. Headache. 1991;31:329–32.

    Article  PubMed  CAS  Google Scholar 

  55. Kohlenberg RT, Cahn T. Self-help treatment for migraine headaches: a controlled outcome study. Headache. 1981;21:196–200.

    Article  PubMed  CAS  Google Scholar 

  56. Mitchell KR, White RG. Control of migraine headache by behavioral self-management: a controlled case study. Headache. 1976;16:178–84.

    Article  PubMed  CAS  Google Scholar 

  57. Cordingley G, Holrody K, Pingel J, Jerome A, Nash J. Amitriptyline versus stress management therapy in the prophylaxis of chronic tension headache. Headache. 1990;30:300.

    Google Scholar 

  58. Warner G, Lance JW. Relaxation therapy in migraine and chronic tension headache. Med J Australia. 1975;1:298–301.

    PubMed  CAS  Google Scholar 

  59. Daly EJ, Donn PA, Galliher MJ, Zimmerman JS. Biofeedback applications to migraine and tension headache: a double-blinded outcome study. Biofeedback & Self-Regulation 1983;8:135–52.

    Article  CAS  Google Scholar 

  60. Kaushik R, Kaushik RM, Mahajan SK, Rajesh V. Biofeedback assisted diaphragmatic breathing and systematic relaxation versus propranolol in long term prophylaxis of migraine. Complement Ther Med 2005;13:165–74.

    Article  PubMed  Google Scholar 

  61. Lockett DC, Campbell JF: The effects of aerobic exercise on migraine. Headache 1992;32:50–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, University of Pittsburgh, 3550 Terrace St., A-1305 Scaife Hall, Pittsburgh, Pennsylvania, 15261, USA

    Dawn A. Marcus

  2. Division of Arthritis & Rheumatic Diseases (OP09), Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA

    Atul Deodhar MD

Authors
  1. Dawn A. Marcus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Atul Deodhar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dawn A. Marcus .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Marcus, D.A., Deodhar, A. (2011). Headache. In: Fibromyalgia. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1609-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1609-9_5

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1608-2

  • Online ISBN: 978-1-4419-1609-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation